Furthermore, ER stress induces high expression of IL-6 and IL-8 to mediate radioiodine resistance in thyroid cancer cells; curcumin as well as the molecularly targeted drug sorafenib can inhibit ER stress to reduce the resistance of thyroid cancer cells to radioiodine (Zhang, 2017). This evidence concerns the gene IL6 and thyroid gland carcinoma.